Effect of <i>Lactobacillus reuteri</i> on Gingival Inflammation and Composition of the Oral Microbiota in Patients Undergoing Treatment with Fixed Orthodontic Appliances: Study Protocol of a Randomized Control Trial
Kevimy Agossa,
Marie Dubar,
Grégoire Lemaire,
Alessandra Blaizot,
Céline Catteau,
Emmanuël Bocquet,
Laurent Nawrocki,
Emile Boyer,
Vincent Meuric,
Florence Siepmann
Affiliations
Kevimy Agossa
Univ. Lille, Inserm, CHU Lille, U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
Marie Dubar
Department of Periodontology, School of Dentistry, University of Lille, Place de Verdun, F-59000 Lille, France
Grégoire Lemaire
Department of Periodontology, School of Dentistry, University of Lille, Place de Verdun, F-59000 Lille, France
Alessandra Blaizot
Department of Dental Public Health, School of Dentistry, CHU Lille, Univ. Lille, F-59000 Lille, France
Céline Catteau
Department of Dental Public Health, School of Dentistry, CHU Lille, Univ. Lille, F-59000 Lille, France
Emmanuël Bocquet
Department of Orthodontics, School of Dentistry, CHU Lille, Univ. Lille, F-59037 Lille, France
Laurent Nawrocki
Department of Oral Surgery, School of Dentistry, CHU Lille, Univ. Lille, F-59037 Lille, France
Emile Boyer
INSERM, INRAE, Université de Rennes 1, CHU de Rennes, Nutrition Metabolisms and Cancer, F-35000 Rennes, France
Vincent Meuric
INSERM, INRAE, Université de Rennes 1, CHU de Rennes, Nutrition Metabolisms and Cancer, F-35000 Rennes, France
Florence Siepmann
Univ. Lille, Inserm, CHU Lille, U1008—Controlled Drug Delivery Systems and Biomaterials, F-59000 Lille, France
The effect of probiotics in improving or maintaining oral health in orthodontic patients is understudied. The aim of this study is to evaluate the effect of probiotic administration in addition to tooth brushing on clinical gingival inflammation, plaque formation, subgingival microbiota composition, and salivary biomarkers of inflammation in adolescents with fixed orthodontic appliances. The present study is a 6-month, double-blind, two-arm, placebo-controlled, single-center trial, in which 116 adolescent volunteers aged 12–16 years will be recruited from the patients of the orthodontics clinic of the University Hospital of Lille, France. Subjects who meet the eligibility criteria will be allocated to one of the following groups: (i) control: two placebo lozenges per day for 90 days together with regular oral hygiene, (ii) test: two probiotic lozenges per day for 90 days together with regular oral hygiene. Clinical assessment and biological sample collection will be performed at baseline, 3 and 6 months. In addition, compliance outcomes and adverse events will be monitored.